Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Carcinoma Stage III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003125
What this trial is testing

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+3 more
Georgetown University 24
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT02539537
What this trial is testing

Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic CancerCarcinoma
UNICANCER 171
Early research (Phase 1)UnknownNCT03236883
What this trial is testing

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IIIPancreatic Cancer Stage IV
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT03073785
What this trial is testing

Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage I Pancreatic Cancer AJCC v6 and v7+7 more
University of Nebraska 46
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00161213
What this trial is testing

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Medicine and Dentistry of New Jersey 44
Not applicableStudy completedNCT00898482
What this trial is testing

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Not applicableStudy completedNCT00900003
What this trial is testing

Studying Biomarkers in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Vanderbilt-Ingram Cancer Center 53
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04539808
What this trial is testing

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage 0 Pancreatic Cancer American Joint Committee on Cancer v8Stage I Pancreatic Cancer American Joint Committee on Cancer v8+2 more
OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00634725
What this trial is testing

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 820
Testing effectiveness (Phase 2)Study completedNCT00003591
What this trial is testing

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 122
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Large-scale testing (Phase 3)Looking for participantsNCT06998940
What this trial is testing

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+2 more
SWOG Cancer Research Network 94
Testing effectiveness (Phase 2)Study completedNCT01128296
What this trial is testing

Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Amer Zureikat 35
Testing effectiveness (Phase 2)Study completedNCT00003810
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Large-scale testing (Phase 3)Ended earlyNCT00428597
What this trial is testing

Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Who this might be right for
Carcinoma, Islet CellCarcinoma, Pancreas
Pfizer 171
Next Page
42